FDA applicant

Diabetes Technologies, Inc.

Thomasville, GA1 decision2002–20020 recalls

FDA records 1 decision for Diabetes Technologies, Inc. (Thomasville, GA) in 2002: 1 510(k) clearance. All are in product code LCP (Assay, Glycosylated Hemoglobin). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, hematology panel, where it files most

How often FDA has decided Diabetes Technologies, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Diabetes Technologies, Inc. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Diabetes Technologies, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Diabetes Technologies, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Diabetes”

FDA records each applicant name separately; these may or may not be the same firm.

Diabetes Sentry Products, LLC 1 Diabetes Technologies, Inc. (Dti) 1

Diabetes Technologies, Inc.

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Diabetes”